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doi:10.1016/j.ejvs.2010.07.007Abstract Objective: To evaluate the proximal and distal (iliac) fixation of seven self-expanding
endografts, used in the endovascular treatment (EVAR) of abdominal-aortic aneurysm (AAA), by
measuring the displacement force (DF) necessary to dislocate the devices from their fixation sites.
Methods: A total of 20humancadaveric aortaswereexposed, left in situand transected to serve as
fixation zones. The Anaconda, EndoFit aorto-uni-iliac, Endurant, Powerlink, Excluder, Talent and
Zenith stent grafts were deployed and caudal forcewas applied at the flowdivider, through a force
gauge. The DF needed to dislocate each device  20 mm from the infrarenal neck was recorded
before and after moulding-balloon dilatation. Cephalad force was similarly applied to each iliac
limb to assess distal fixation before and after moulding-balloon dilatation.
Results: Endografts with fixation hooks or barbs displayed a significantly higher DF necessary to
dislocate the proximal portion compared with devices with no such fixation modalities
(p < 0.001). Balloon dilatation produced a significant increase in DF in both devices with
(p < 0.001) or without (pZ 0.003) hooks or barbs. Suprarenal support did not enhance proximal
fixation (pZ 0.90). Balloon dilatation significantly increased the DF necessary to dislodge the iliac
limbs (pZ 0.007).
Conclusions: Deviceswithfixationhooks displayedhigherproximal fixation.Moulding-balloondila-
tation increased proximal and distal fixation. Suprarenal support did not affect proximal fixation.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.earch Unit, Russell’s Hall Hospital, Dudley Group of Hospitals NHS Foundation Trust, Dudley, West
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The proximal and distal fixation of an endograft following
endovascular repair (EVAR) of abdominal-aortic aneurysm
(AAA) is vital, to exclude endoleak, graft migration and sac
repressurisation, all of which can prove catastrophic. The
proximal fixation of a device depends on a number of
factors relating to the aorta and the stent graft itself, such
as the contour and size of the attachment zones, the
presence of thrombus, the shape and size of the graft, the
ability of the graft to provide radial spring force and various
device specifications, including balloon or self-expanding
deployment, the presence of fixation hooks and barbs and
the configuration of the device’s skeleton.1,2
Various investigators have attempted to evaluate the
fixation force of the endografts used in EVAR, employing
different models,3e10 in human cadaveric aortas or, most
commonly, animal cadaveric aortas. However, some of these
studies have only tested graft fixation in animals,10 while
others have only assessed proximal fixation without taking
distal fixation into account.7 Additionally, there are no
studies focussing on graft fixation pre- and post- moulding-
balloon dilatation. Moreover, there is insufficient data con-
cerning the distal (iliac limb) fixation of the endografts
against cephalad forces, similar to the forces causing type I
distal migration seen in thoracic aortic endografts, which
resemble the type of force that is applied to the distal (iliac)
portion of any EVAR device.9,11e15
This study aims to assess the proximal and distal fixation
of seven commercially available aortic endografts
(Anaconda (Vascutek, Inchinnan, Scotland, UK), EndoFit
aorto-uni-iliac (LeMaitre Vascular, Burlington, MA, USA),
Endurant (Medtronic, Minneapolis, MN, USA), Endologix
Powerlink (Endologix, Irvine, CA, USA), Excluder (Gore
Medical, Flagstaff, AZ, USA), Talent (Medtronic, Minneap-
olis, MN, USA) and Zenith (Cook Medical, Bloomington, IN,
USA)) pre- and post- moulding-balloon dilatation in a model
using human cadaveric aortas.
Methods
A total of 20 human cadavers (Department of Pathology,
Aristotle University Medical School, Thessaloniki, Greece)
were included (inclusion criteria: time of death  18 h;
absence of intra-abdominal pathology or abdominal trauma;
intact femoral and iliac vessels andabsenceof sepsis).Written
informed consent was obtained in all cases by the family.
Institutional Review Board approval was also obtained.
The Mecmesin Digital Basic Force Gauge (BFG) 200 and
MultiTest stand (Mecmesin Limited, Newton House, West
Sussex, UK) were employed to measure the DFs. The
specific device has been previously validated.16
The sevenendografts included in the studywere chosenas
they have distinct characteristics aimed to enhance fixation,
such as, proximal fixation hooks, unibody skeletondesign and
sophisticated proximal and distal fixation mechanisms using
ring stents to enhance friction against the aorticwall. Table 1
summarises the characteristics of the endografts.
Through a midline laparotomy, the retro-peritoneum
was uncovered and dissected, and each aorta was surgically
prepared by displaying the vessel from the coeliac axis tothe level of the internal iliac arteries. The actual diameter
of the aorta was measured in the following manner, using
a caliper: after the aorta was surgically exposed and prior
to dissecting the vessel, arterial clamps were temporarily
applied at the level of the suprarenal aorta, the renal
arteries, the distal common iliac arteries and any patent
lumbar arteries. The isolated abdominal aorta was
sequentially dilated with saline using an inflation device at
100 mm Hg through the inferior mesenteric artery stump, to
ensure that the aortic and iliac artery diameters correlated
with the diameter of the vessels in vivo. The clamps were
then withdrawn and the abdominal aorta was dissected
from 20 mm below the origin of the most distal renal artery
and up to the level of the aortic bifurcation to serve as
proximal and distal fixation zones (‘experimental AAA’), as
previously described in similar studies,.2e10 The tempera-
ture of the cadaveric aorta was kept at 37 C by means of
a warm normal saline bath (a probe was embathed into the
saline bath, adjacent to the proximal aorta). Warmed
normal saline was also used during the exposure of the
femoral arteries and during endograft insertion and
deployment to ensure adequate expansion of the self-
expanding grafts. The femoral arteries were exposed and
prepared in standard fashion. The endografts were
deployed following femoral artery catheterisation in
a standard fashion, according to the manufacturer’s spec-
ifications by NM and NS, both of whom have had previous
experience (> 10 procedures for each device) using the
specific devices. A 10e20% oversizing Tables 1 and 2 was
employed in all cases (proximal and distal attachment
zones), according to our department’s routine policy for
EVAR and the manufacturers’ instructions. In general, we
tested a total of three previously unused endografts of the
same proximal and distal diameter for each device. The
adequate proximal and distal fixations of the devices were
confirmed macroscopically, without using fluoroscopy.
Once the devices had been removed, the lengths of the
proximal and distal fixation zones were measured, con-
firming that the affixated part was between 19 and 21 mm
in all cases. A nonabsorbable coated braided polyester
suture was attached to the flow divider of the graft Fig. 1.
The suture’s elastic properties were tested prior to the
experiments; a force > 90 N was necessary for the suture to
deform. The distal end of the suture was attached to the
Mecmesin BFG gauge in a 15 angle.11 Incremental force
was applied through a motorised displacement-measuring
test stand at a speed of 100 mm min1. The DF necessary to
dislocate the graft from its proximal fixation site for 20 mm
was measured following the full deployment (proximal and
distal landing zones) of each device (for devices with and
without fixation hooks or barbs). This DF represents the
maximal force recorded by the gauge whilst applying
incremental force at 100 mm min1. Measurements were
obtained for each graft prior and post dilatation using
a Reliant moulding-balloon (Medtronic, Minneapolis, MN,
USA). A manual inflation device was used to control infla-
tion pressure. The DF necessary to dislodge the distal (iliac)
part of each graft proximally for at least 20 mm was also
measured in a similar manner following full deployment of
the iliac legs pre- and post balloon dilatation; however,
force was applied in the opposite direction (cephalad force,
distal/proximal) to simulate the type of force that would
Table 1 Characteristics of the 7 different endografts that were used in the study.
Name Affiliation Type of device Type of fabric Proximal
fixation
Configuration of
the skeleton
Fixation hooks,
barbs, pins
Anaconda Vascutek,
Inchinnan,
Scotland, UK
Three (3) pieces
bifurcated
Woven
polyester
Infrarenal Indepented SE nitinol
fish-mouth ring stents;
exoskeleton
Yes (Y)
EndoFit AUI LeMaitre
Vascular,
Burlington,
MA, USA
One-piece
unibody AUI
Ultrathin
PTFEe2 layers
Suprarenal
17 mm length
Indepented SE
nitinol Z stents;
encapsulated within
2 layers of PTFE
No (N)
Endurant Medtronic,
Minneapolis,
MN, USA
Two (2) pieces
bifurcated
Multi filament
polyester
Suprarenal
15 mm length
Indepented SE nitinol
M and Z stents;
exoskeleton
Y
Endologix
powerlink
Endologix,
Irvine,
CA, USA
One-piece
unibody
bifurcated
PTFE Infrarenal Unibody skeleton
made from
cobalt chromium
interconnected alloy;
endoskeleton
N
Excluder Gore, Flagstaff,
AZ, USA
Two (2) pieces
bifurcated
PTFE Infrarenal Independent
asymmetric nitinol
Z and M stents;
exoskeleton
Y
Talent Medtronic,
Minneapolis,
MN, USA
Two (2) pieces
bifurcated
Polyester Suprarenal
15 mm length
Independent
SE nitinol Z stents;
exoskeleton
N
Zenith Cook Medical,
Bloomington,
IN, USA
Three (3) pieces
bifurcated
Dacron Suprarenal
26 mm length
Independent SE stainless
steel Z stents;
exoskeleton (stents
at landing
zones are internal)
Y
AUI: aorto-uni-iliac, PTFE: poly-tetra-fluoro-ethylene, SE: self-expanding.
Endograft Fixation 431be applied against the distal portion of an endograft when
fully deployed in vivo. Each cadaveric aorta was used 2 or 3
times, as in previous studies2e10. The intimal layer was
considered as damaged if there was macroscopical disrup-
tion of the tissue. Grafts with fixation hooks or barbs were
deployed last; no further measurements were obtained
after a device with such modalities had already been
deployed once. Additionally, when moulding-balloon dila-
tation had been employed, the cadaver was not used for
any further measurements.Statistical Analysis
All analyses were made using the Statistical Package for the
Social Sciences (SPSS) version 13.0 for Windows. All vari-
ables were analysed using the ShapiroeWilk or Kolmogor-
oveSmirnov test (according to the size of the distribution)
to assess the normality of each distribution. Median and
range are given for non-normally distributed variables and
mean and standard deviation (SD) or range are given for
normally distributed variables. The Wilcoxon test (paired
non-parametric data), ManneWhitney test (independent
non-parametric data) and Student’s t-test (paired para-
metric data) were used to compare differences between
two groups. Differences among more than two groups were
analysed using analysis of variance (ANOVA). A p value
< 0.05 was considered as statistically significant.Results
The mean age of the cadavers was 57 years (range: 51e84
years; 14 men). Six patients were diagnosed with coronary
artery disease (CAD), eight with arterial hypertension
(receiving pharmaceutical treatment), nine had a history of
hyperlipidaemia and 12 were smokers; none had a history of
aneurysmal disease. The mean diameter of the aortas
(infrarenal proximal neck) was 20.5 mm (range:
19.2e21.9 mm). The cadaveric aortas were divided into
three groups according to the amount of calcification: (1)
minimal (n Z 6); (2) moderate (n Z 7); and (3) heavy
(calcified plaques extending  1/3 of the vessel’s perim-
eter; n Z 7). Each endograft was deployed in all three
types of aortas. None of the cadavers had excessive calci-
fication; no thrombus was detected prior to graft insertion
at the level of the attachment zones. Since three different
endografts were available for each device, each separate
graft was only deployed twice. Table 2 summarises the
proximal and distal diameters of the devices used and the
amount of oversizing applied in each case. Results are
summarised in Tables 3 and 4.
The Zenith endograft recorded the highest DF necessary
to dislocate the graft 20 mm from its proximal fixation site
following full deploymentof themainbodyand the iliac limbs
and balloon dilatation (p < 0.001, ANOVA; mean DF:
39.30 1.55 N); the Anaconda showed the second highest DF
(mean: 36.16  1.30 N); the aorto-uni-iliac EndoFit graft
Figure 1 Schematic description of the experimental
protocol.
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432 N. Melas et al.displayed the lowest DF (mean: 13.20  0.75 N) Table 3.
Endografts equipped with fixation hooks or barbs (Zenith,
Anaconda, Endurant and Excluder) displayed a significantly
higher DF necessary to dislocate the proximal portion of the
graft  20 mm compared with devices with no such fixation
modalities (Talent, Powerlink, Endofit), following full graft
deployment with balloon dilatation (p < 0.001, Man-
neWhitney test, median: 36.10 N (range: 21.85e40.90 N) vs.
median: 14.80 N (range: 12.50e16.65 N)). Balloon dilatation
produced a significant increase in DF in both stent grafts
equipped with hooks or barbs (p < 0.001, paired sample t-
test, mean: 26.97  6.44 N vs. 32.45  6.71 N) and devices
without such modalities (p Z 0.003, paired sample t-test,
mean: 13.58  1.46 vs. mean: 14.72  1.41) e Table 4.
Devices with suprarenal support did not exhibit an increased
proximal fixation ability (p Z 0.90, ManneWhitney test,
median: 16.20 N (range: 12.50e40.90 N) vs. median: 22.60
(range: 14.10e37.50 N)) e Table 3.
Regarding distal fixation (iliac legs), the Anaconda
device displayed the maximal DF necessary to dislocate the
iliac limbs for  20 mm (p < 0.001, ANOVA, 14.58  0.68 N),
Table 3 Displacement force necessary to dislocate the
device > Z 20 mm: 1) From the proximal fixation zone
(proximal/distal). 2) From the distal (iliac) fixation zone
(distal/proximal), following balloon dilatation. Data pre-
sented as mean  standard deviation in Newton.
1 (Proximal) 2 (Distal)
Talent 16.18  0.47 9.23  1.25
Anaconda 36.16  1.30 14.58  0.68
Gore 22.58  0.72 10.52  0.40
AUI EndoFit 13.20  0.75 8.83  0.48
Zenith 39.30  1.55 9.55  1.52
Endurant 31.75  2.27 9.65  0.43
Endologix 14.80  0.70 4.93  0.50
AUI: aorto-uni-iliac.
Endograft Fixation 433followed by the Excluder (mean: 10.51  0.40 N); the
Endologix device displayed the lowest DF (mean:
4.93  0.50 N) e Table 3. Balloon dilatation significantly
increased the DF necessary to dislodge the distal fixation
zones (p Z 0.007, Wilcoxon test, median: 9. 50 N (range:
4.55e15.30 N) vs. median: 9.05 N (range: 4.35e14.10 N)).
Discussion
This analysis attempted to evaluate the proximal and distal
fixation of seven endografts used in EVAR, all of which
employ distinct fixation modalities. The Zenith, a modular
three-piece bifurcated device with suprarenal support and
3 mm-long fixation barbs (‘anchors’), displayed the
maximal proximal fixation capability. In general, devices
incorporating hooks or barbs (Table 4) displayed signifi-
cantly better fixation in the current model. Balloon dila-
tation also significantly impacted on proximal and distal
fixation; however, suprarenal support did not have
a significant effect (p Z 0.90) among these devices.
Previous studies have shown that an endograft needs to
withstand pulsatile drag forces of 3.8e6 N in an aneurysmal
aorta with a friendly anatomy and drag forces up to 14 N in
more hostile anatomies.11,17,18 All devices used in this
analysis have exceeded these limits.
The fact that the Zenith and the Anaconda endografts
displayed the maximal fixation can possibly be explained by
the existence of rigid hooks and barbs at their proximal
portion. Previous research has shown that such modalities
significantly enhance fixation.3e5 The Zenith, in addition toTable 4 Results: displacement force (in Newton) necessary to d
fixation zone.
Grafts with hooks or barbs Grafts wi
Median: 36.10 (range: 21.85e40.90) Median: 1
Infrarenal fixation Supraren
Median: 22.60 (range: 14.10e37.50 N) Median: 1
Grafts with hooks or barbs Pre balloon dilatation
Mean: 26.97  6.44 (S
Grafts with no hooks or barbs Pre balloon dilatation
Mean: 13.58  1.46 (S
SD: standard deviation.its 10 fixation barbs (3 mm in length), offers suprarenal
support through a 26-mm-long suprarenal fixation mecha-
nism, significantly longer than the suprarenal stents of any
other device. Suprarenal support has been shown to have
a positive effect on graft migration,11,17e23 even though this
was not proven in the current study (Table 4). The long
main body of the Zenith device may also play a role, as it
provides a higher amount of columnar support. Resch et al.7
and Veerapen et al.24 have also shown that the Zenith has
a high proximal fixation capability compared with other
self-expanding devices. The Anaconda proved the second
highest overall fixation. The specific device incorporates
a sophisticated proximal fixation mechanism consisting of
four pairs of 2-mm-long metallic hooks and double over-
sized stiff rings, which provide radial force as they expand
against the aortic wall. Any attempt to migrate the stent
distally produced a visible movement of these oversized
proximal stents during our experiment. Bosman et al.19
recently included the Anaconda, Endurant, and the
Excluder in a similar study showing a significantly higher DF
for the Anaconda. The Endurant bears a proximal fixation
mechanism with Z and M nitinol stents with five pairs of 2-
mm-long hooks and a 15-mm-long suprarenal fixation stent.
The fact that its proximal fixation is lower can probably be
attributed to the smaller length of the suprarenal fixation
stents (15 mm vs. 26 mm) and the anchoring pins (2 mm vs.
3 mm), as well as the different material of which the stents
and pins are made (nitinol vs. stainless steel). The Excluder
has been previously tested by Veerapen et al.24 and Bosman
et al.19 and has been shown to necessitate a lower DF
compared with the Zenith and the Endurant. The device
incorporates eight pairs of 2 mm nitinol fixation barbs and
no suprarenal support. Regarding the results for the Talent
endoprosthesis, these are similar to the DFs seen in the
studies by Veerapen et al.24 and Resch et al.7; the device
does not incorporate fixation hooks or barbs, but is equip-
ped with a 15-mm nitinol suprarenal stent. As far as the
Powerlink device is concerned, it needs to be noted that
the major advantage of the prosthesis is the high amount of
columnar support that it provides, given its unibody
configuration. Due to lack of proximal aortic cuffs of
adequate length, the device was not deployed as it would
be in vivo, where the distal portion lies against the aortic
bifurcation; therefore, supporting the main body of the
prosthesis. As a result, the DF seen in this study does not
probably correlate to the DF needed for the device to
migrate in vivo. The EndoFit aorto-uni-iliac device does not
have fixation hooks, but it does incorporate suprarenalislocate the proximal portion of the graft >Z 20 mm from its
th no hooks or barbs p
4.80 (range: 12.50e16.65) < 0.001
al support - fixation
6.20 N (range: 12.50e40.90 N) 0.90
Post balloon dilatation
D) Mean: 32.45  6.71 (SD) < 0.001
Post balloon dilatation
D) Mean: 14.72  1.41 (SD) Z 0.003
434 N. Melas et al.fixation. Despite the relatively low DF seen in this study, in
a group 106 patients treated with the device in our centre,
the rate of type 1 endoleak was 2.83% (long-term data)25
and it did not prove inferior compared with bifurcated
prostheses over a midterm follow-up.26,27
Overall, the presence of fixation hooks and barbs has
significantly impacted on fixation. However, the presence
of hooks, did macroscopically affect the integrity of the
aortic wall. In vivo, we have not encountered any such
complications in a cohort of 51 patients treated with the
Anaconda over a midterm follow-up and we are not aware
of any such complications in the literature.28,29 Moulding-
balloon dilatation also had a positive effect, both proxi-
mally and distally. Balloon dilatation against proximal,
distal and overlapping zones is applied when intra-opera-
tive type I endoleak has been encountered. This study
suggests that it may in fact enhance fixation. However, we
could not propose routine dilatation since, theoretically, it
may lead to complications such as renal embolisation.
Regarding suprarenal support, it did not significantly
affect fixation among these seven endografts; however, the
device with the maximal fixation incorporates a long supra-
renal support mechanism. It should be noted that suprarenal
support has been linked with decreased renal function;
however, most data so far are largely contradictory.30
An important observation was the amount of force neces-
sary tomigrate the distal (iliac) legs of the prostheses, as iliac
fixation does affect overall fixation.20,31 The Anaconda limbs
recorded the maximal DF. This can probably be attributed to
the fish-mouth ring stents, identical to the type of fixation
mechanism incorporated at the Anaconda’s proximal portion.
Any attempt to dislocate the iliac limbs produced a macro-
scopically visible movement of the ‘fish-mouth’ stents, which
increased the friction of the vessel wall. The other devices
incorporate iliac limbs made of Z stents.
The limitations of this study include the fact that the
cadaveric aortas used were not aneurysmal, the proximal and
distal necks were not mechanically connected, and the tor-
tuosityeangulation of the aortas could not be adequately
reproduced. Additionally, we only used uniaxial DF in a non-
pulsatile manner. The DFs in vivo are rotational and pulsatile.
However, previous investigators using similar models applying
uniaxial forces have reported similar results with various
endografts.3e10,19 Finally, force-displacement curves couldnot
be obtained owing to the study’s design and the use of a force
gauge and not a dynamometer to assess fixation. A significant
advantage of this study is the fact that the aortas used were
human and not animal and were tested, in situ. This allows
safer conclusions to be made, especially since, besides the
properties of the vessel’swall, the proximal necks in allmodels
using animal aortas are significantly smaller in diameter.Conclusion
This study has attempted to assess the proximal and distal
fixation of seven different endovascular devices used in
AAA repair, in an experimental model using human cadav-
eric aortas. The Zenith and Anaconda devices displayed the
maximal proximal fixation. Fixation hooks and moulding-
balloon dilatation seem to increase fixation. Suprarenal
support per se did not affect the overall fixation.Conflict of Interest
None.
Funding
None.
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